Frequently asked questions Does injecting GLP-1 hurt
// :
What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care Brandon Aylward Oct 16, 2025 10 min read Few categories in modern medicine have captured the imagination of patients, physicians, and investors as quickly as GLP-1 receptor agonists (GLP-1s)
The Acarbose Cardiovascular Evaluation (ACE) trial, which enrolled 7,500 Chinese subjects (of which 6,522 completed the trial) with coronary heart disease and impaired glucose tolerance, found acarbose treatment for four months reduced the incidence of diabetes and promoted regression to normoglycemia (Gerstein 2020)
There are no separate per-visit fees
- Th ba, thnh phn Glutathione thi c t, chng oxy ha da v thi ra mt s loi kim loi khi c th